PATENT CLAIM ANALYSIS

Application Number: 15894696
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "428000"]

Abstract:
Prostamide-containing biodegradable intraocular implants, prostamide compounds, prostamide-containing pharmaceutical compositions, and methods for making and using such implants and compositions for the immediate and sustained reduction of intraocular pressure and treatment of glaucoma in an eye of a patient are described.

Claim (Index 8):
A method for reducing intraocular pressure in a patient, comprising administering a therapeutically effective amount of a therapeutic agent directly into the anterior chamber of an eye in the patient, thereby reducing intraocular pressure in the eye, wherein the therapeutic agent has the formula

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.375
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14211265', '15075922', '14529526', '15350471', '14213294']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8016905769229299
- 35 USC 102 Novelty (BERT): 0.5844099759934644
- Combined Prediction Score: 0.7799625168299833
- Mean Citation Score: 483.80722
- Max Citation Score: 568.7078
- Similarity Product: 402.6693955411315

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test